FDA
approval
· 2012-09-10
FDA Approved: ZYRTEC HIVES — Supplemental Application (Kenvue Brands LLC)
Summary
FDA approved a supplemental application for ZYRTEC HIVES (cetirizine hydrochloride) and finalized its label to cover the treatment of hives (urticaria).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ZYRTEC HIVES (CETIRIZINE HYDROCHLORIDE)